Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency.
暂无分享,去创建一个
S. Holland | D. Kleiner | A. Freeman | N. Yazigi | T. Heller | N. Shah | D. Hickstein | S. Kaufman | K. Khan | M. Parta | P. Atkinson
[1] William M. Lee,et al. Herpes Simplex Virus–Associated Acute Liver Failure Often Goes Unrecognized , 2019, Hepatology.
[2] R. Champlin,et al. Delay of alternative antiviral therapy and poor outcomes of acyclovir‐resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant – a retrospective study , 2018, Transplant international : official journal of the European Society for Organ Transplantation.
[3] F. Tandoi,et al. Successful Sequential Liver and Hematopoietic Stem Cell Transplantation in a Child With CD40 Ligand Deficiency and Cryptosporidium-Induced Liver Cirrhosis , 2018, Transplantation.
[4] D. Porter,et al. Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease. , 2018, Blood advances.
[5] N. Rastogi,et al. Reduced‐toxicity alternate‐donor stem cell transplantation with posttransplant cyclophosphamide for primary immunodeficiency disorders , 2018, Pediatric blood & cancer.
[6] I. Tezcan,et al. Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome , 2018, Bone Marrow Transplantation.
[7] D. Gladstone,et al. HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities. , 2017, Hematology. American Society of Hematology. Education Program.
[8] Yu-Hong Chen,et al. Risk factors for herpes simplex virus-1/2 viremia and clinical outcomes following unmanipulated haploidentical haematopoietic stem cell transplantation. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] M. Yılmaz,et al. Hematopoietic stem cell transplantation from unrelated donors in children with DOCK8 deficiency , 2017, Pediatric transplantation.
[10] Thomas E. Hughes,et al. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[11] P. Richardson,et al. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[12] A. Hawwari,et al. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. , 2017, Clinical immunology.
[13] E. Fuchs. Related haploidentical donors are a better choice than matched unrelated donors: Point. , 2017, Blood advances.
[14] Thomas E. Hughes,et al. Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency. , 2016, The journal of allergy and clinical immunology. In practice.
[15] Douglas R. McDonald,et al. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. , 2016, The Journal of allergy and clinical immunology.
[16] M. Abecassis,et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation , 2016, Bone Marrow Transplantation.
[17] Elias T. Zambidis,et al. Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[18] T. Kawai,et al. Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance , 2016, Advances in hematology.
[19] R. D'Agostino,et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. , 2016, Blood.
[20] T. Fleisher. Transplantation Outcomes for Severe Combined Immunodeficiency 2000–2009 , 2015, Pediatrics.
[21] S. Solomon,et al. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] H. Kong,et al. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] J. Orange,et al. DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients , 2015, Journal of Clinical Immunology.
[24] J. Crawford,et al. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). , 2014, Journal of Clinical and Experimental Hepatology.
[25] M. Gobbi,et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] L. Notarangelo,et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. , 2014, The New England journal of medicine.
[27] S. Solomon,et al. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor , 2014, Bone Marrow Transplantation.
[28] A. Borkhardt,et al. Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment. , 2014, Clinical immunology.
[29] R. Nelson,et al. Recent Advances in Transplantation for Primary Immune Deficiency Diseases: A Comprehensive Review , 2014, Clinical Reviews in Allergy & Immunology.
[30] D. Sachs,et al. Tolerance induction: hematopoietic chimerism , 2013, Current opinion in organ transplantation.
[31] D. Sachs,et al. Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[32] Douglas B. Johnson,et al. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation? , 2012, Experimental hematology.
[33] A. Woolfrey,et al. Hematopoietic cell transplantation for treatment of primary immune deficiencies. , 2010, Cellular therapy and transplantation.
[34] Allen R. Chen,et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[35] S. Holland,et al. Combined immunodeficiency associated with DOCK8 mutations. , 2009, The New England journal of medicine.
[36] H. Friess,et al. Herpes simplex virus sepsis and acute liver failure , 2009, Clinical transplantation.
[37] L. Notarangelo,et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. , 2008, The Journal of allergy and clinical immunology.
[38] B. Portmann,et al. Liver disease in children with primary immunodeficiencies. , 2001, The Journal of pediatrics.
[39] T. Lion,et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis , 2000 .
[40] G. Mufti,et al. Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. , 2000, The New England journal of medicine.
[41] K. Ishak,et al. Recurring fibro-obliterative venopathy in liver allografts. , 1999, The American journal of surgical pathology.
[42] T. Starzl,et al. Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance , 1993, Hepatology.
[43] N. Callander,et al. Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients. , 1992, Bone marrow transplantation.
[44] R. Storb,et al. Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis. , 1991, Blood.